Related Experiment Video
Updated: Apr 14, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Comparative Effectiveness of Omeprazole and Lansoprazole in Gastroesophageal Reflux Disease (GERD): A Review Article
Rizky Gustinanda1, Febby Zulkarnain2, Merry Permatasari2
1Faculty of Pharmacy, Ahmad Dahlan University, Campus III Soepomo, Warungboto, Umbulharjo, Yogyakarta, Postal Code 55164, Indonesia.
Abstract:
This review discusses the use of Omeprazole and Lansoprazole as therapy in patients with Gastroesophageal Reflux Disease (GERD). GERD is a digestive tract disorder caused by repeated reflux of stomach contents into the esophagus. GERD is often characterized by symptoms of a burning and burning chest (heartburn). The most widely used pharmacological therapy to treat GERD is Proton Pump Inhibitor (PPI) drugs, such as Omeprazole and Lansoprazole with a working mechanism that inhibits the proton pump that H+ ions exit from the gastric parietal cells. The method used in writing this article review is an electronic literature study by accessing national and international journal search sites. The results obtained are based on effectiveness, Omeprazole is more effective and faster in reducing and maintaining gastric acid pH. Based on the adverse effects of the drug, Omeprazole has a lower potential risk of causing diarrhea. Omeprazole has the most minimal cost analysis when viewed from the cost aspect and Omeprazole has a faster onset than Lansoprazole.
More Related Videos
08:25Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
Published on: August 27, 2021
04:05Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy
Published on: August 22, 2025
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...